Malay Shah, MD
Transplant Surgery · Lexington, KYNPI 1649390543
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,620 of the $4,825 with a category attached, or 95.8%. Transmedics, Inc. accounts for 95.8% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $2,649, more than ten times the $17 reported in 2019.
Across 9 payments — averaging $536.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$5K
- Merck$96
- BD$69
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$39
Across 8 payments — averaging $12,939 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Transmedics, Inc.$104K
What the payments were for
- Travel & lodging$4,62096%
- Food & beverage$2044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 5 | $4,620 |
| Merck | 1 | $96 |
| BD | 1 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGAN CARE SYSTEM$4,620
How this compares
Too few transplant surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 20 | $3,053 |
| Dapsone | 18 | $110 |
| Prednisone | 16 | $101 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Lexington
- Alejandro Cracco MahechaLexington$5K
- Meera GuptaLexington$3K
- Siddharth DesaiLexington$3K
- Alexandre AnchetaLexington$3K
- Matthew BlackLexington$2K
- Erin MaynardLexington$536
- Roberto GedalyLexington$135
- Eric DavisLouisville$78K
- Christopher JonesLouisville$34K
- Mary EngLouisville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.